| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |